[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate

C37H51N9O4 — CID 91475683

IUPAC[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate
SMILESCc1cc(C(C)C(NC(=O)ON2CCC(N3CCc4ccccc4NC3=O)CC2)C(=O)N2CCC(N3CCN(C)CC3)CC2)cc2cn[nH]c12
InChIInChI=1S/C37H51N9O4/c1-25-22-28(23-29-24-38-41-33(25)29)26(2)34(35(47)44-13-9-30(10-14-44)43-20-18-42(3)19-21-43)40-37(49)50-45-15-11-31(12-16-45)46-17-8-27-6-4-5-7-32(27)39-36(46)48/h4-7,22-24,26,30-31,34H,8-21H2,1-3H3,(H,38,41)(H,39,48)(H,40,49)
InChIKeyGSSBMCUOHMTXCV-UHFFFAOYSA-N
MW685.87 g/mol
LogP3.78
Rot. Bonds7

About [4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate

[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate (PubChem CID 91475683) has the molecular formula C37H51N9O4 and a molecular weight of 685.87 g/mol. Its IUPAC name is [4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate.

Molecular Properties

Compound Name[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate
PubChem CID91475683
Molecular FormulaC37H51N9O4
Molecular Weight685.87 g/mol
Exact Mass685.41
IUPAC Name[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate
SMILESCc1cc(C(C)C(NC(=O)ON2CCC(N3CCc4ccccc4NC3=O)CC2)C(=O)N2CCC(N3CCN(C)CC3)CC2)cc2cn[nH]c12
InChIInChI=1S/C37H51N9O4/c1-25-22-28(23-29-24-38-41-33(25)29)26(2)34(35(47)44-13-9-30(10-14-44)43-20-18-42(3)19-21-43)40-37(49)50-45-15-11-31(12-16-45)46-17-8-27-6-4-5-7-32(27)39-36(46)48/h4-7,22-24,26,30-31,34H,8-21H2,1-3H3,(H,38,41)(H,39,48)(H,40,49)
InChIKeyGSSBMCUOHMTXCV-UHFFFAOYSA-N
XLogP3.78
TPSA129.38 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds7
Heavy Atoms50
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500685.87
LogP ≤ 53.78
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Analyze [4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate?
The IUPAC name of [4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate (CID 91475683) is [4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate.
What is the SMILES notation for [4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate?
The canonical SMILES for [4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate is Cc1cc(C(C)C(NC(=O)ON2CCC(N3CCc4ccccc4NC3=O)CC2)C(=O)N2CCC(N3CCN(C)CC3)CC2)cc2cn[nH]c12.
What is the InChIKey of [4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate?
The InChIKey is GSSBMCUOHMTXCV-UHFFFAOYSA-N. The full InChI is InChI=1S/C37H51N9O4/c1-25-22-28(23-29-24-38-41-33(25)29)26(2)34(35(47)44-13-9-30(10-14-44)43-20-18-42(3)19-21-43)40-37(49)50-45-15-11-31(12-16-45)46-17-8-27-6-4-5-7-32(27)39-36(46)48/h4-7,22-24,26,30-31,34H,8-21H2,1-3H3,(H,38,41)(H,39,48)(H,40,49).
What are the key properties of [4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate?
[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate has a molecular weight of 685.87 g/mol, XLogP of 3.78, 7 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for [4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl] N-[3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxobutan-2-yl]carbamate is sourced from PubChem (CID 91475683), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).